InvestorsHub Logo
icon url

Ernesto

01/06/16 1:37 PM

#135770 RE: Jhawker #135769

Trial results are all that are required. They company has not provided any in over a year. The stock was bumped up to over $4 on B Phase 2b and Kevetrin tumor hype. We will likely get some trial results on all four of our compounds in 2016.